Sonoma Pharmaceuticals (SNOA) Shares Outstanding (Weighted Average) (2010 - 2025)

Sonoma Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $1.7 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 17.01% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (up 17.01% YoY), while the FY2025 annual figure was $1.2 million, up 172.75% from the prior year.
• Shares Outstanding (Weighted Average) was $1.7 million for Q4 2025 at Sonoma Pharmaceuticals, up from $1.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $4.9 million in Q2 2023 to a low of $2219.0 in Q3 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
• The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Weighted Average) plunged 99.88% in 2021, then surged 159074.46% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2507.0 in 2021, then soared by 123832.99% to $3.1 million in 2022, then tumbled by 88.7% to $351000.0 in 2023, then soared by 317.09% to $1.5 million in 2024, then increased by 17.01% to $1.7 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.7 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.